
Opinion|Videos|April 25, 2025
Closing Perspectives
Experts discuss how to evaluate the cost-effectiveness of continuous glucose monitoring (CGM) compared to traditional monitoring, considering both clinical and quality outcomes, and what combination of economic and quality data would most effectively support broader CGM adoption across health systems and payer organizations.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- How do you evaluate the cost-effectiveness of CGM compared to traditional monitoring when considering both clinical and quality outcomes?
- What: combination of economic and quality data would most effectively support broader CGM adoption across health systems and payer organizations?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
House Republicans Block Vote on ACA Subsidy Extension
2
Study Suggests Adding BTKi to Chemo May Improve Early Outcomes in Richter Transformation in CLL
3
Zasocitinib Hits Phase 3 End Points in Plaque Psoriasis
4
FDA Approval of Subcutaneous Amivantamab Offers Faster, Safer Option for EGFR-Mutated NSCLC
5









































